ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why QL2107 is on this study

  • No treatment in the record names it; a reading of the whole record found it given.
  • Claude Opus 5.5 judged it given beside what the study tests. Nov 1, 2026, 8:22 AM UTC
  • The role rule had no answer: no treatment entry names it.
  • So QL2107's page lists this study under “Given beside what is tested”.
7 links1 made here, not in the record7 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06949761A Clinical Study toEvaluate the Safety,Tolerability, and Efficacyof QLC1101 in CombinationWith Other Therapies in theTreatment of Patients WithAdvanced Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1/Phase 2 · not yet recrRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSSolid TumorNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSKRAS G12D Inhibitor QLC1101Entry “QLC1101+QL1203”, read by our n…›Nov 18 · Rule based · TestedTestedQL1203Entry “QLC1101+QL1203”, read by our n…›Nov 18 · Rule based · TestedTestedINT035530Entry “QLC1101+QL2107”, read by our n…›Nov 18 · Rule based · TestedTestedIparomlimab/TuvonralimabEntry “QLC1101+QL1706”, read by our n…›Nov 18 · Rule based · TestedTestedDocetaxelEntry “QLC1101+docetaxel”, read by ou…›Nov 18 · Rule based · TestedTestedQL2107Made here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1QL2107made hereClaude Opus 5.5BackgroundCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14Solid TumorRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18KRAS G12D Inhibitor QLC1101Rule based · role ruleTestedCurrent
Nov 18QL1203Rule based · role ruleTestedCurrent
Nov 18INT035530Rule based · role ruleTestedCurrent
Nov 18Iparomlimab/TuvonralimabRule based · role ruleTestedCurrent
Nov 18DocetaxelRule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.